About this trial
The Impact of Health Literacy on the Attitudes toward Pharmacological Treatment in Patients with Schizophrenia Spectrum Disorder
This interventional study is aimed at:
* assessing and improving the health literacy and * assessing the attitude towards treatment of patients with schizophrenia spectrum disorders while they are admitted to the inpatient psychiatric unit.
Eligibility criteria
Qualifiers
Patients admitted to the University Medical Center-New Orleans (UMCNO) inpatient behavioral health unit ages 18 and older with a new or previous diagnosis of schizophrenia spectrum disorder outside of substance use disorders
Patients must be proficient in English.
Patients must have a government issued social security number (required for reimbursement through the university).
Disqualifiers
Patients at UMCNO that are ages 17 or younger
Patients with SSD and concomitant intellectual disability, as evidenced by prior documented history on chart review or patients suspected to have intellectual disability or impairment based on clinical interactions
Patients with concomitant substance use and documentation of psychosis being resolved after a period of washout and without the use of psychotropic medications
Patients unable to complete health literacy assessments, attitude towards treatment assessments, and IQ testing due to severity of symptoms during hospitalization
Trial design
Treatments tested in this trial
- Educational sessions
Treatment groups
Sponsors and collaborators
Louisiana State University Health Sciences Center in New Orleans
Lead sponsor
Janssen Pharmaceuticals
Collaborator